Antiretroviral Drugs

handshake deal shake hand arrows ok yes
Favicon Fierce Pharma

Merck prepares expanded access to monthly PrEP pill early

Merck is launching the global access strategy before the phase 3 trial evaluating alimatravir for HIV PrEP has completed enrollment or produced data.
Angus Liu Jul 24, 2026 10:40am
sink faucet drain

Immunocore bispecific reduces HIV reservoir in early trial

Mar 10, 2025 3:00pm
Electromicrograph showing an HIV-infected T cell in blue and yellow

HIV protein inhibited by Rukobia linked to cardio comorbidities

Nov 30, 2023 9:30am
H9-T cell infected by HIV

HIV drug hydrogel extends treatment longevity to 6 weeks

Sep 25, 2023 2:00pm